Concepedia

Atsushi Otake

AO

3

Publications

65

Citations

3

H-Index

1993

Active since

Affiliations

Hamamatsu University School of Medicine(Current)

Toray (United States)

Atsushi Otake is an author at Hamamatsu University School of Medicine specializing in hematology, drug discovery, and pharmacotherapy.

Top concepts

MedicineHematologyThrombosisPharmacologyDrug DiscoveryPharmacotherapyBiochemistryInflammationNatural SciencesVascular Biology

Publications per year

1993–2003

3

Publications

3

Cilostazol, a novel cyclic AMP phosphodiesterase inhibitor, prevents reocclusion after coronary arterial thrombolysis with recombinant tissue-type plasminogen activator.

Sei Saitoh, Tomiyoshi Saito, Atsushi Otake et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1993 · 40 citations · Full text

TRA-418, a novel compound having both thromboxane A2 receptor antagonistic and prostaglandin I2 receptor agonistic activities: its antiplatelet effects in human and animal platelets

Naohiro Yamada, M. Miyamoto, Masafumi Isogaya et al. · Journal of Thrombosis and Haemostasis · 2003 · 13 citations

Thrombopoiesis, Thrombosis, Blood Platelet +11

Effects of TRA‐418, a novel TP‐receptor antagonist, and IP‐receptor agonist, on human platelet activation and aggregation

Mitsuko Miyamoto, Naohiro Yamada, Shiho Ikezawa et al. · British Journal of Pharmacology · 2003 · 12 citations · Full text

Platelet Pathobiology, Pharmacotherapy, Platelet Aggregation +24

Rows per page

1–3 of 3